Angiotensin II failitated angiogenesis mediated through macrophage migration inhibitory factor activation in hindlimb ischemic
Angiotensin II failitated angiogenesis mediated through macrophage migration inhibitory factor activation in hindlimb ischemic
批准号:
16590654
负责人:
FUKUZAWA Jun
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Background-Macrophage migration inhibitory factor (MIF), which we have reported to be secreted by oxidative stress, plays a crucial role in several inflammatory conditions such as regulating the activation of macrophages and T cells, and it also acts as a factor stimulating cell growth and inducing other cytokines and enzymes such as vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs). VEGF and MMPs are thought to influence neovascularization in many cell type. Taken together, we assessed the hypothesis that MIF could be an important factor stimulating angiogenesis in response to ischemia. Methods and Results-To test the hypothesis, we examined angiogenesis in response to tissue ischemia in MIF overexpressed (TG) mice. We applied surgically-induced unilateral hindlimb ischemia model to MIF TG and wild type (WT) mice (C57BL/6). Angiogenesis and collateral vessel formation in the ischemic hindlimb were analyzed by using laser Doppler perfusion Imager (ischemic/normal perfusion ratio), angiography (angiogrphic score) and histological capillary density with vWF antibody. Message and protein expression of the VEGF and MMPs (-2 and -9) were determined with RT-PCR. Angiogenesis and collateral vessel formation in response to hindlimb ischemia were markedly increased in MIF TG mice compared with WT mice. VEGF protein levels were not different between the MIF TG mice and WT mice at non-ischemic area. In the ischemic area VEGF mRNA and protein expression levels were increased in the TG mice compared with the WT mice. MMP-9 mRNA expression was increased at non-ischemic region in the TG mice compared with the WT mice. This increased expression was reinforced in the ischmic region in the TG mice, although no difference in MMP-2 between them. A neutralizing antibody against MIF significantly suppressed angiogenesis, VEGF expression, and MMP-9 expression in response to ischemia
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
生体防御レクチンとしてのコレクチンファミリー
作为生物防御凝集素的集合素家族
DOI:
--
发表时间:
2004
期刊:
北海道医学雑誌 79(1)
影响因子:
--
作者:
[若宮伸隆, 吉田逸朗, 小笠原正洋, 福澤純, 大谷克城, 小山聡]
通讯作者:
小山聡
DOI:
10.1172/jci200421382
发表时间:
2004-09-01
期刊:
JOURNAL OF CLINICAL INVESTIGATION
影响因子:
15.9
作者:
[Fujino, T, Nakagawa, N, Ushikubi, F]
通讯作者:
Ushikubi, F
慢性腎不全患者における酸化LDLと動脈硬化進展
慢性肾功能衰竭患者氧化低密度脂蛋白与动脉硬化进展
DOI:
--
发表时间:
2005
期刊:
ノーステック財団研究開発助成事業研究成果報告書2004.
影响因子:
--
作者:
[福澤純, 矢尾尚之, 板部洋之, 菊池健次郎, 松谷Knox洋子.]
通讯作者:
松谷Knox洋子.
INSIGHT(サブ解析)
洞察力(子分析)
DOI:
--
发表时间:
2004
期刊:
臨床高血圧 10
影响因子:
--
作者:
[福澤純, 小山聡, 櫻木均, 矢尾尚之, 長谷部直幸, 菊池健次郎.]
通讯作者:
菊池健次郎.
血液透析と酸化ストレス.
血液透析和氧化应激。
DOI:
--
发表时间:
2004
期刊:
血圧 10
影响因子:
--
作者:
[矢尾尚之, 福澤純, 小山聡, 櫻木均, 森本寛, 羽根田俊, 長谷部直幸, 菊池健次郎.]
通讯作者:
菊池健次郎.
共 12 条
Role of macrophage migration inhibitory factor on the progression of the aortic aneurysm
-
批准号:19590846
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:FUKUZAWA Jun
-
依托单位:
Constitutive Subthreshold Signal by Local Renin-Angiotensin System Facilitates the Cardiotrophin-1-Induced Strong Activation of JAK/STAT Signaling Pathway and Cardiomyocyte Hypertrophy
-
批准号:14570629
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2002
-
负责人:FUKUZAWA Jun
-
依托单位:
国内基金
海外基金
登录
查看更多内容
SDC1通过MMP11+CAF的细胞外基质重塑促进子宫颈癌化学免疫联合治疗耐药的机制研究
-
批准号:JCZRQNB202600504
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于“大气下陷”理论探讨升陷汤调控IL-17A/IL-17RA信号轴抑制MMP-2/MMP-9表达抗心衰大鼠心肌纤维化的作用机制
-
批准号:2026JJ80502
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王雪
-
依托单位:
生殖支原体感染以MMP28为枢纽介导细胞外基质重塑及组织损伤的机制研究
-
批准号:2026JJ80225
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谭湘芳
-
依托单位:
CMA/溶酶体轴失衡驱动的MMP13核转位及转录调控在骨关节炎中的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:徐瑞菱
-
依托单位:
脾脏巨噬细胞糖酵解重编程促进细胞活化及MMP9表达介导川崎病炎症反应和冠状动脉病变的机制研究
-
批准号:JCZRLH202601362
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
Er - Nd:YAG双激光联合治疗种植体周围炎前后龈沟液MMP-8、IL-Iβ细胞因子变化与临床疗效关系研究
-
批准号:2026JJ82235
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曾婷雯
-
依托单位:
ADAM17通过调控MMP21促进肝细胞癌进展和M2型巨噬细胞极化
-
批准号:2026JJ82501
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:向宇琦
-
依托单位:
RSV非结构蛋白“劫持“宿主表观调控酶激活MMP-9转录致血脑屏障损伤及丙戊酸靶向干预研究
-
批准号:2026JJ50575
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谭宇蓉
-
依托单位:
细菌纤维素复合敷料的电响应设计及其调控创面MMP-9/TIMP-1 通路促烧伤创面愈合机制研究
-
批准号:2026JJ82603
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:吴迎
-
依托单位:
溴莫尼定通过cAMP/PKA/CREB轴调控MMP-2表达延缓近视眼轴增长的机制研究
-
批准号:2026JJ70126
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:向爱群
-
依托单位: